levodopa has been researched along with Charcot-Marie-Tooth Disease, Demyelinating, Type 4f in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirano, M; Imai, T; Ito, H; Kawamura, J; Matsumoto, S; Tamaru, Y; Ueno, S | 1 |
| Dyck, PJ; Jaradeh, S | 1 |
1 trial(s) available for levodopa and Charcot-Marie-Tooth Disease, Demyelinating, Type 4f
| Article | Year |
|---|---|
Hereditary motor and sensory neuropathy with treatable extrapyramidal features.
Topics: Adult; Aged; Basal Ganglia Diseases; Carbidopa; Drug Combinations; Female; Hereditary Sensory and Motor Neuropathy; Humans; Levodopa; Male; Middle Aged; Peripheral Nervous System Diseases; Placebos | 1992 |
1 other study(ies) available for levodopa and Charcot-Marie-Tooth Disease, Demyelinating, Type 4f
| Article | Year |
|---|---|
Clinical similarities of hereditary progressive/dopa responsive dystonia caused by different types of mutations in the GTP cyclohydrolase I gene.
Topics: Adolescent; Adult; Age of Onset; Case-Control Studies; Circadian Rhythm; Disease Progression; DNA; Dopamine Agents; Exons; Female; Genetic Carrier Screening; GTP Cyclohydrolase; Hereditary Sensory and Motor Neuropathy; Humans; Japan; Levodopa; Male; Middle Aged; Mutation; Pedigree; Sequence Analysis, DNA | 1998 |